Variables | HFNO group | Venturi mask group |
---|---|---|
(n = 52) | (n = 48) | |
Age, yr, median [25th–75th percentile] | 59.3 [43–70] | 64.5 [53.25–72] |
Males, n (%) | 38 (73.1) | 32 (66.7) |
Comorbidities, n (%) | ||
Chronic respiratory failure | 7 (13.5) | 4 (8.3) |
Chronic kidney failure | 2 (3.8) | 3 (6.2) |
Chronic heart failure | 4 (7.7) | 2 (4.2) |
Cause of immunosuppression, n (%) | ||
Solid malignancy | 15 (28.8) | 8 (16.7) |
Hematological malignancy | 31 (59.6) | 30 (62.5) |
HIV infection | 3 (5.8) | 5 (10.4) |
Steroid treatment | 13 (25.0) | 15 (31.2) |
Other immunosuppressant drugs | 23 (44.2) | 14 (29.2) |
Final etiology of ARF,b n (%) | ||
Sepsis | 25 (48.1) | 25 (52.0) |
Cardiogenic pulmonary edema | 5 (9.6) | 2 (4.1) |
Noninfectious pulmonary disease | 5 (6.8) | 7 (14.5) |
Lung involvement by the underlying disease | 7 (13.4) | 9 (18.7) |
Large pleural effusion | 0 (0) | 1 (2.0) |
Pneumocystis pneumonia | 5 (9.6) | 2 (4.1) |
Miscellaneousc | 3 (5.7) | 1 (2.0) |
No diagnosis | 2 (3.8 %) | 1 (2.0) |
SAPS II at ICU admission, median [25th–75th percentile] | 42 [29.5–52] | 37.5 [31.5–46.5] |
SOFA score at randomization, median [25th–75th percentile] | 3.5 [2–6] | 3 [2–5] |
Days since respiratory symptom onset | 3 [2–8] | 3 [2–7.25] |
Clinical status at randomization | ||
Respiratory rate, breaths/min, median [25th-75th percentile] | 26 [21.7–31.2] | 27 [22–32.2] |
SpO2, %, median [25th-75th percentile] | 96 [94–98] | 96 [95–98.2] |
Estimated PaO2/FiO2 ratio at admission | 128 [48–178] | 100 [40–156] |
Mean arterial pressure, mmHg, median [25th-75th percentile] | 86.8 [82.2–95.3] | 80 [74–89.3] |
Normal Glasgow Coma Scale score, n (%) | 49 (94.2) | 48 (100) |
Confusion, n (%) | 4 (7.7) | 1 (2.1) |